Drug ID: | NPD5686 |
Drug Name: | Ribociclib |
Molecular Formula: | C23H30N8O |
Canonical SMILES: | CN(C(=O)c1cc2c(n1C1CCCC1)nc(=Nc1ccc(cn1)N1CCNCC1)[nH]c2)C |
Standard InCHI: | InChI=1S/C23H30N8O/c1-29(2)22(32)19-13-16-14-26-23(28-21(16)31(19)17-5-3-4-6-17)27-20-8-7-18(15-25-20)30-11-9-24-10-12-30/h7-8,13-15,17,24H,3-6,9-12H2,1-2H3,(H,25,26,27,28) |
Standard InCHIKey: | RHXHGRAEPCAFML-UHFFFAOYSA-N |
Max Developmental Stage: | Approved |
Max Developmental Stage Source: | ChEMBL; IUPHAR/BPS |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DIB001419 |
DrugBank | DB11730 |
ChEMBL | CHEMBL3545110 |
IUPHAR/BPS | 7383 |
PharmaGKB | |
KEGG Drug | |
PubChem CID | 44631912 |
ChEBI | |
CAS Number | 1211441-98-3 |
Molecular Weight | 434.25 |
ALogP | -3.3232 |
MLogP | 3 |
XLogP | 1.875 |
HDA | 9 |
HBD | 2 |
Rotatable Bonds | 7 |
TPSA | 90.15 |
RO5 Violation | 0 |